MRI-based vector radiomics for predicting breast cancer HER2 status and its changes after neoadjuvant therapy.

MLA

Zhang, Lan, et al. “MRI-Based Vector Radiomics for Predicting Breast Cancer HER2 Status and Its Changes after Neoadjuvant Therapy.” Computerized Medical Imaging and Graphics : The Official Journal of the Computerized Medical Imaging Society, vol. 118, Oct. 2024, p. 102443. EBSCOhost, https://doi.org/10.1016/j.compmedimag.2024.102443.

APA

Zhang, L., Cui, Q.-X., Zhou, L.-Q., Wang, X.-Y., Zhang, H.-X., Zhu, Y.-M., Sang, X.-Q., & Kuai, Z.-X. (2024). MRI-based vector radiomics for predicting breast cancer HER2 status and its changes after neoadjuvant therapy. Computerized Medical Imaging and Graphics : The Official Journal of the Computerized Medical Imaging Society, 118, 102443. https://doi.org/10.1016/j.compmedimag.2024.102443

Chicago

Zhang, Lan, Quan-Xiang Cui, Liang-Qin Zhou, Xin-Yi Wang, Hong-Xia Zhang, Yue-Min Zhu, Xi-Qiao Sang, and Zi-Xiang Kuai. 2024. “MRI-Based Vector Radiomics for Predicting Breast Cancer HER2 Status and Its Changes after Neoadjuvant Therapy.” Computerized Medical Imaging and Graphics : The Official Journal of the Computerized Medical Imaging Society 118 (October): 102443. doi:10.1016/j.compmedimag.2024.102443.